Headlands Technologies’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,642
| Closed | -$486K | – | 1519 |
|
|
2025
Q1 | $486K | Buy |
31,642
+25,657
| +429% | +$394K | 0.06% | 293 |
|
|
2024
Q4 | $132K | Buy |
+5,985
| New | +$132K | 0.01% | 613 |
|
|
2024
Q3 | – | Sell |
-11,493
| Closed | -$187K | – | 1535 |
|
|
2024
Q2 | $187K | Sell |
11,493
-3,713
| -24% | -$60.3K | 0.02% | 493 |
|
|
2024
Q1 | $215K | Buy |
15,206
+11,745
| +339% | +$166K | 0.05% | 355 |
|
|
2023
Q4 | $36.1K | Sell |
3,461
-16,858
| -83% | -$176K | 0.01% | 581 |
|
|
2023
Q3 | $207K | Sell |
20,319
-6,803
| -25% | -$69.4K | 0.1% | 194 |
|
|
2023
Q2 | $204K | Buy |
+27,122
| New | +$204K | 0.07% | 277 |
|
|
2023
Q1 | – | Sell |
-274
| Closed | -$2K | – | 748 |
|
|
2022
Q4 | $2K | Buy |
+274
| New | +$2K | ﹤0.01% | 455 |
|